Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus

World Journal of Gastroenterology

Volumn 12, Issue 42, 2006, Pages 6792-6796

  Altindis, Mustafa ^a,b,f   Yilmaz, Sebahattin ^c   Dikengil, Tansel ^d   Acemoglu, Hamit ^e   Hosoglu, Salih ^e  

^a AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Military Hospital   (Cyprus)

^c Dr Akçiçek State Hospital   (Cyprus)

^d Turkish Republic of Northtern Cyprus   (Cyprus)

^e DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^f NONE   (Turkey)

Author keywords

Cyprus; Donor; Healthy adults; Hepatitis B; Hepatitis C; Human immunodeficiency virus

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CYPRUS; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SEROLOGY; SEROPREVALENCE; SOLDIER; TURKEY (REPUBLIC); VIRUS CARRIER;

EID: 33751353760     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i42.6792     Document Type: Article

References (20)

1. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BF. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125
2. Gasiorowicz M, Hurie M, Russell A, Hoxie N, Vergeront J. Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin. WMJ 2006; 105: 34-39
3. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13 Suppl 1: S47-S49
4. Demirel Y, Duran B, Toktamis A, Erden O, Cetin M. Seroprevalence of syphilis, hepatitis B and C, and human immunodeficiency virus infections among women. Saudi Med J 2004; 25: 2037-2038
5. Ozsoy MF, Oncul O, Cavuslu S, Erdemoglu A, Emekdas G, Pahsa. A. Seroprevalences of hepatitis B and C among health care workers in Turkey. J Viral Hepat 2003; 10: 150-156
6. Altuglu I, Sayiner AA, Erensoy S, Zeytinoglu A, Bilgic A. Screening for human immunodeficiency virus type 1 and 2 in a Turkish blood donor population. Int J Infect Dis 1998; 2: 202-204
7. Kyriakides T, Eleftheriou. A, Michaelides N, Papantoniou. L. Surveillance of HIV in the army of the Republic of Cyprus (SHARC); rationale, design, and implementation of an inexpensive system. Sex Transm Infect 2002; 78:50-52
8. Mitchell PS, Sloan LM, Majewski DW, Rys PN, Heimgartner PJ, Rosenblatt JE, Cockerill FR 3rd, Smith TF, Patel R. Comparison of line probe assay and DNA sequencing of 5′ untranslated region for genotyping hepatitis C virus: description of novel line probe patterns. Diagn Microbiol Infect Dis 2002; 42:175-179
9. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006; 21: 299-305
10. Gunduz T, Mumcuoglu L Guray M. Evaluation of hepatitis B surface antigen, anti-hepatitis C virus and anti-human immunodeficiency virus antibodies and syphilis seropositivity in blood donors: six years' seropositivity. Int J Clin Pharmacol Res 2005; 25: 155-158
11. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001; 41: 652-658
12. Kyriakis KP, Foudoulaki LE, Papoulia EI, Sofroniadou KE. Seroprevalence of hepatitis B surface antigen (HBsAg) among first-time and sporadic blood donors in Greece: 1991-1996. Transfus Med 2000; 10: 175-180
13. Papaevangelou G, Roumeliotou A, Chatziminas M, Kotsianopoulou M, Ioannou. P, Trichopoulou E, Nestoridou A. Epidemiological characteristics of hepatitis B virus infection in Cyprus. Eur J Epidemiol 1988; 4:150-153
14. Karaoglu L, Pehlivan E, Gunes G, Genc M, Tekerekoglu SM, Ercan C, Egri M, Yologlu S. Evaluation of the immune response to hepatitis B vaccination in children aged 1-3 years in Malatya, Turkey. New Microbiol 2003; 26: 311-319
15. Janot C, Courouce AM, Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet 1989; 2: 796-797
16. Mutlu B, Meric M, Willke A. Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors. Mikrobiyol Bul 2004; 38: 445-448
17. Richter SS. Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol 2002; 40: 4407-4412
18. Selcuk H, Kanbay M, Korkmaz M, Gur G, Akcay A, Arslan H, Ozdemir N, Yilmaz U, Boyacioglu S. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Dig Dis Sci 2006; 51:1420-1425
19. Abacioglu YH, Davidson F, Tuncer S, Yap PL, Ustacelebi S, Yulug N, Simmonds P. The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 1995; 2: 297-301
20. Koulentaki M,. Spanoudakis S, Kantidaki E, Drandakis P, Tzagarakis N, Biziagos E, Moschandrea J, Kouroumalis EA. Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study. J Viral Hepat 1999; 6: 243-248